Biotech Reports Filter by Date 2023 2022 2021 2020 2019 2018 Category Cell and Gene Therapy CNS Dermatology Gastrointestinal Hematology Infectious Disease Metabolic Rare Disease Regulatory/ DDC/ FDA Respiratory Immunology Liver Disease Oncology September 22, 2023 Report Primary Biliary Cholangitis – Global Clinical Trial Landscape (2023) Primary biliary cholangitis (PBC) is a chronic liver condition characterized by T-cell lymphocyte-mediated damage to bile ducts, potentially leading to biliary cirrhosis and liver failure if left u Download September 1, 2023 Report Nasopharyngeal Carcinoma: Global Clinical Trial Landscape Nasopharyngeal carcinoma is the most common cancer originating from the nasopharyngeal epithelium and is often undifferentiated. It is mainly found in Asia and Africa. Download August 28, 2023 Report Gallbladder Cancer: Global Clinical Trial Landscape Gallbladder cancer develops when malignant cells proliferate in the mucosal layer of the gallbladder and expand outward. Download June 28, 2023 Report Head and Neck Cancer-Global Clinical Trial Landscape-Focus on Asia Pacific Asia accounted for nearly 65% of the global Head and Neck cancer incidence in 2020. Download June 26, 2023 Report Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific Asia accounted for more than 70% of worldwide liver cancer incidence cases in 2020, with China contributing the majority. Download May 26, 2023 Report Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific Asia accounted for more than 40% of the world's Non-Hodgkin Lymphoma incidence in 2020, with China contributing the majority. Download May 24, 2023 Report Crohn’s Disease-Global Clinical Trial Landscape-Focus on Asia Pacific Asia particularly Australia and New Zealand show the highest incidence rates of Crohn's Disease, while East Asia has shown a rising trend in both incidence and prevalence since 2015. Download April 28, 2023 Report Ovarian Cancer - Global Clinical trial landscape- Focus on Asia Pacific Asia accounted for more than half of the global Ovarian Cancer incidence cases in 2020, with majority of them contributed by China and India. Download April 27, 2023 Report Melanoma - Global Clinical trial landscape- Focus on Asia Pacific Asia contributed close to 24,000 melanoma cases in 2020, with Australia and New Zealand having the highest incidence rates in the world. Download April 6, 2023 Report Breast Cancer- Global Clinical Trial Landscape- Focus on Asia Pacific Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing the majority of cases. Download April 5, 2023 Report Prostate Cancer Global Clinical trial landscape - Focus on Asia Pacific In 2020, Asia accounted for more than a quarter of worldwide Prostate cancer incidence cases, with China and Japan together contributing over 220,000 new cases in the region. Download March 3, 2023 Report Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific Asia Pacific accounted for approximately 46,000 AML cases in 2020, with China, India, and Japan accounting for 40% of the global cases. Download February 20, 2023 Report Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific India and China show the highest prevalence of Rheumatoid arthritis, with 10 million and 5 million cases respectively, with the most rapidly growing age-standardized incidence and prevalence rates Download January 19, 2023 Report Alzheimer’s Disease Alzheimer’s disease is the most common cause of dementia, and the Asia Pacific region is expected to contribute to more than half of all global dementia cases by 2030. Download January 9, 2023 Report Idiopathic Pulmonary Fibrosis - Asia Pacific – Clinical Trial Landscape The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF. Download December 16, 2022 Report Chronic Obstructive Pulmonary Disease (COPD)-Asia Pacific- Clinical trial landscape The Asia-Pacific region had a COPD prevalence rate of 13.5% in 2019, exceeding the global average, with Mainland China showing the highest prevalence. Download December 8, 2022 Report Peanut Allergy Asia Pacific – Clinical trial landscape Similar to the west, Australia in the APAC region has the highest rate of peanut allergy affecting around 3% of children. Download November 25, 2022 Report Glaucoma Asia Pacific – Clinical trial landscape Owing to a large and ageing population base, Asia accounts for more than 60% of the estimated global cases of glaucoma. Download November 18, 2022 Report Diabetic Retinopathy Asia Pacific – Clinical Trial Landscape Asia-Pacific region accounts for 51% of all blindness cases and 56% of cases of visual impairment worldwide due to Diabetic Retinopathy Download October 12, 2022 Report Paroxysmal nocturnal hemoglobinuria (PNH) According to estimates, 1-2 cases per million people develop PNH annually in Western nations, while the rate is roughly 10 per million each year in Asia, with China and India showing the highest in Download October 10, 2022 Report C3 Glomerulopathy (C3G) From 1990 to 2019, Asia, particularly South Asia experienced the greatest increase in age-standardized incidence and prevalence rates of Glomerulonephritis compared to the West. Download September 29, 2022 Report Bile duct cancer (Cholangiocarcinoma) Asia Pacific – Clinical Trial Landscape Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South Korea, Thailand, and Taiwan having the highest incidence rates in Download September 27, 2022 Report Ulcerative colitis asia pacific – clinical trial landscape UC incidence and prevalence have rapidly increased in Asia over the past four decades, particularly in Australia and Japan Download September 1, 2022 Report Non-alcoholic steatohepatitis (NASH) Asia Pacific – Clinical trial landscape Asia accounted for nearly 15% of the overall prevalence of Clostridium difficile infection with a death rate nearing 10% in 2019. Download September 1, 2022 Report Clostridium Difficile Infection (CDI) Asia Pacific – Clinical Trial Landscape Asia accounted for nearly 15% of the overall prevalence of Clostridium difficile infection with a death rate nearing 10% in 2019. Download August 22, 2022 Report Diffuse large b-cell Lymphoma – Asia Pacific – Clinical trial landscape Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide. Download August 2, 2022 Report Brain/central nervous System (cns) tumors – Asia pacific – clinical Trial landscape Asia accounted for more than 50% of the global incidence of brain and CSN tumor in 2020, with Mainland China, India, and Japan contributing to majority of the cases. Download July 28, 2022 Report Psoriasis - Asia Pacific –Clinical Trial Landscape Of the approximately 30 million adult Psoriasis cases that were prevalent globally in 2017, the highest prevalences were found in the Asian region particularly India, Mainland China, and Japan. Download July 27, 2022 Report Solid tumors - Asia Pacific – Clinical trial Landscape There were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the region accounting for half of the new cancer cases and 60% of the world’s deaths in 2020. Download July 13, 2022 Report Multiple myeloma - Asia pacific – clinical Trial landscape Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global incidence, with China, India, and Japan comprising more than a quarter Download July 13, 2022 Report Covid-19 - asia pacific – Clinical trial landscape Asia Pacific accounts for around 20% of the total COVID-19 cases reported globally with Taiwan, Australia, Japan, and South Korea reporting the highest number of new cases of COVID-19 in the region Download June 22, 2022 Report Parkinson’s disease - Asia pacific – clinical Trial landscape Due to the presence of half of the world’s aging population and a high population growth rate in APAC, the global burden of Parkinson's Disease is expected to rise, with China, Japan, and India col Download June 15, 2022 Report Acute pancreatitis – Asia pacific – clinical Trial landscape Owing to its huge, aged population base, Asia accounts for over 55% of the estimated global incidence of Acute pancreatitis, with China, Japan, and India collectively contributing to over a quarter Download June 15, 2022 Report Chronic pain - Asia pacific – clinical Trial landscape In Asia Pacific, Chronic Pain affects more than half of the population, with China and India together contributing close to 700 million cases. Download May 26, 2022 Report Follicular lymphoma - Asia pacific - clinical Trial landscape Owing to its large population base, Asia may account for over 40% of the estimated global incidence of Follicular Lymphoma, with China, Japan and India collectively contributing to over a quarter o Download May 26, 2022 Report Atopic dermatitis Asia has been witnessing increasing levels of Atopic Dermatitis (AD) over the previous few decades, with the Paediatric AD prevalence rates in various Asian ethnicities reaching as high as 20%. Download May 24, 2022 Report Renal Cell Carcinoma Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma, with China, Japan, and India collectively contributing to over a quarter of Download March 31, 2022 Report Triple negative breast Cancer With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for more than half of all TNBC cases, with a large TNBC patient pool, particularly in Download March 17, 2022 Report Disease report - CKD - APAC - CT Landscape Diabetes and hypertension are expected to drive the global prevalence of CKD, with much of this increasing burden observed in Asian locations of China and India. Download March 14, 2022 Report Hepatitis B - Asia Pacific - Clinical trials Landscape The Asia-Pacific with an intermediate to high prevalence, represents three-quarters of chronic hepatitis B (CHB)-positive subjects worldwide. Download February 24, 2022 Report Small cell lung cancer Each year, there are over 300,000 new cases of Small Cell Lung Cancer globally, with Asia accounting for nearly 60% of the cases. Download January 21, 2022 Report Bladder cancer Asia accounted for over a third of the global bladder cancer incidence with over 200,00 newly diagnosed cases, with China having a higher prevalence of bladder cancer in 2020. Download January 21, 2022 Report Thyroid cancer Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates found in Australia and Eastern Asia for both sexes. Download December 17, 2021 Report Cervical cancer Asia pacific Clinical trial landscape Asia accounts for almost 60% of the global incidence of cervical cancer, with India and China together contributing to more than a third of all cases and deaths. Download December 17, 2021 Report Pancreatic cancer Clinical trials landscape Asia pacific The incidence of pancreatic cancer is rising in Asia-Pacific, with the region accounting for about half of new cases in 2020. Download December 17, 2021 Report Gastric cancer Clinical trial landscape Asia-pacific Nearly 75% of the new gastric cancer cases in the world are concentrated in Asia, with China showing the highest incidence and mortality. Download November 29, 2021 Report Colorectal cancer clinical trials landscape asia pacific The incidence of colorectal cancer cases is rapidly growing in Asia-Pacific and the region now accounts for more than half of all new cases diagnosed globally. Download November 29, 2021 Report Lung cancer (nsclc) clinical trials landscape asia pacific In Asia, lung cancer ranks as the most prevalent cancer and the primary cause of mortality, with the region accounting for almost 60% of the global incidence of lung cancer. Download November 3, 2021 Report Esophageal cancer – Clinical trials landscape – Asia pacific In Asia, EC is the sixth most common cancer, with the region constituting almost 80% of the new EC cases globally. The highest standardized incidence rate has been observed in East Asia. Download October 14, 2021 Report Clinical trial landscape Of cll in asia-pacific CLL is one of the most common forms of leukaemia, with the Asia Pacific region showing increasing incidence. China and South Korea are among the Asian locations showing the greatest incidence. Download October 12, 2021 Report Clinical trial landscape of Liver cancer in asia pacific According to the Globocan 2020 report, liver cancer is the fourth most frequent cancer in Asia, with the region accounting for over 70% of all new liver cancer cases worldwide. Download September 17, 2021 Report Clinical trial landscape of diabetes (type 2) in asia-pacific Diabetes, which is endemic in most Western countries, is now seeing a surge in developing nations across Asia due to aging, urbanization, and changing dietary habits. Download September 17, 2021 Report Clinical trial landscape of endometrial cancer in asia-pacific In 2020, Globocan reported over 400,000 new corpus uteri cases, with Asia accounting for about 40% of these new cases. Download August 27, 2021 Report Clinical trial landscape of B-cell lymphoma in asia-pacific Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and the most aggressive subtype constituting nearly 70% of B-Cell Lymphomas in Asia. Download August 20, 2021 Report Clinical trial landscape of t-cell lymphomas in asia-pacific T-cell lymphomas (TCLs) are types of non-Hodgkin’s lymphoma (NHL) that affect T lymphocytes. Download August 18, 2021 Report Cystic fibrosis-Clinical Trials Landscape-APAC Cystic fibrosis is a rare autosomal recessive disease which primarily affects the lungs and digestive system due to a malfunction in the exocrine system responsible for producing saliva, sweat, tea Download February 15, 2021 Report AML Landscape in Asia-Pacific AML is the most common form of leukemia in adults, accounting for approximately a third of all leukemia cases worldwide. Download February 28, 2020 Report Regulatory requirements for clinical trials in Australia With a streamlined regulatory environment, including no requirement for an IND, and the supportive R&D Government refund of up to 43.5% on clinical research spend, Australia has become a prefer Download February 5, 2020 Report Accelerating Genetic Therapy Clinical Trials in Asia-Pacific A growing number of biotechnology companies, both in the West and in Asia, are specializing in gene therapies and other regenerative treatments boosted by the approval of the first genetic therapy Download February 4, 2020 Report Accelerating Immunotherapy Clinical Trials in Asia-Pacific Over 600 sites across Asia-Pacific have been involved in the clinical development of now approved IO drugs, and hundreds more are experienced in managing clinical trials with immunotherapies for bo Download December 1, 2019 Report Orphan drug trials accelerating in Asia Pacific We have observed an unprecedented effort in the clinical development of Orphan drugs in the recent years. Download Load More
